Cardiovascular Implant Infection Proteomics: Prevention, Diagnostics and Therapy of Implant Infections
According to an estimate from the WHO, infections threatening health will see an increase in the 21st Century. This is caused partly by the worldwide crisis caused by resistance to antibiotics, as well as the demographic developments, which lead to more and more older people requiring implants to ensure a high quality of life.
The aim of Card-ii-Omics is to avoid infections of artificial heart valves by applying a new anti-infectious coating. The difficult diagnosis and therapy of these life-threatening infections should also be improved. In order to achieve considerable improvements in this important health issue, both of the state’s universities, Rostock and Greifswald, are combining their strengths. In Card-ii-Omics, academics and scientists from the areas of biomedical technology, cardiology, infection medicine, microbiology, immunology, as well as proteomics and functional genomics will work together.
The interdisciplinary training of young scientists and academics in medicine, natural and technological sciences ensure the sustainability of the project.
Project Coordinated by the University of Rostock with Participation of University Medicine Greifswald.
Excerpt from the jury’s vote:
“The project specifically joins existing competences of both of the state’s universities/university hospitals. The University of Rostock will bring in its strength in the field of biomedical technology and Greifswald will add its existing competence in proteomics research. Both are respective key fields of research at their universities and can refer to excellent groundwork. This proposed project will be the first time that these two existing scientific clusters have worked together.”
Contact at University Medicine Rostock
Prof. Emil C. Reisinger
Tel.: +49 (0)381 494 7511
Fax: +49 (0)381 494 7509
Department of Tropical Medicine and Infectious Diseases and Section of Nephrology